Figure 7: Skin cancer comparison between patients receiving dual and triple therapy. BCC was the most prevalent complication (*p<0.05). (D): dual therapy; (T) triple therapy; (KAP) Kaposi’s sarcoma; (MALH) Malherbe’s epithelioma.